Course Faculty
Mary Anne Jackson, MD, FAAP
Dr Jackson obtained her medical degree from the University of Missouri-Kansas City School of Medicine. She completed her residency at Children’s Hospital Medical Center in Cincinnati, where she was recognized with the Samuel Dalinsky Memorial Award as the outstanding graduating resident. She then completed her infectious diseases fellowship training at the University of Texas-Southwestern completing an additional year of research in the laboratory of Eric Hansen, PhD. Board-certified in pediatrics and pediatric infectious diseases, she has been a member of the faculty at Children’s Mercy Hospital and Clinics, Kansas, Missouri, since 1984, where she is Division Director of Infectious Diseases and the Associate Chair for Community and Regional Physician Collaboration. She is a fellow of the American Academy of Pediatrics (AAP), the Infectious Disease Society of America (IDSA), and the Pediatric Infectious Disease Society (PIDS), as well as a member of the American Pediatric Society, the Society of Pediatric Research and the Academic Pediatric Association. In 2012, she received the Take Wing award, given to the UMKC SOM graduate for excellence in the practice of medicine, academic medicine, or research. She has served on the editorial boards of Healthy Kids, Concise Reviews in Pediatric Infectious Diseases, was a past member of the editorial board of the Pediatric Infectious Diseases Journal, and served as the medical editor for the infectious diseases subboard for the American Board of Pediatrics. She has been a member of the AAP Committee on Infectious Diseases (Red Book Committee) since 2009, and she currently is the Associate Editor of Red Book 2015. She has authored more than 100 peer-reviewed publications and book chapters. Dr Jackson’s research focuses on strategies to reduce the incidence of hospital-acquired infection, judicious use of antibiotics, treatment of antibiotic resistant infection, and vaccine implementation and education.
Angela L. Myers, MD, MPH, FAAP
Dr Angela L. Myers is the Director of the Pediatric Infectious Disease fellowship program at Children’s Mercy Hospitals and Clinics, Kansas City, Missouri, and Associate Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine. She is a fellow of the American Academy of Pediatrics and a member of the Section on Infectious Diseases (SOID) as well as the Infectious Disease Society of America (IDSA) and the Pediatric Infectious Disease Society (PIDS). She serves on the PIDS Program Training Committee and was part of the first cohort to complete the Association of Pediatric Program Directors Leadership in Education and Academic Development (APPD-LEAD) certificate program. She serves on the editorial board of PREP ID for the AAP, and is currently serving as a writing group member for the American Board of Pediatrics (ABP) to develop guidelines for PID fellowship milestones. She serves on the Centers for Disease Control and Prevention (CDC) writing panel for “Best Practices for Laboratory Testing of Campylobacter spp.” Dr Myers completed her undergraduate training along with her medical degree from the University of Missouri–Kansas City in 2001, where she received the Laura L. Backus, MD, Memorial Award for Excellence in Pediatrics. She completed her pediatric residency at Children’s Mercy Hospitals and Clinics in 2004 as well as a fellowship in Pediatric Infectious Diseases in 2008, along with a Master’s degree in Public Health with honors from the University of Kansas. She joined the faculty at Children’s Mercy Hospital and Clinics in Kansas City, Missouri, in March of 2008. Her current research focuses on optimizing laboratory testing for common infectious conditions as well as implementation strategies to increase influenza vaccine in the high-risk host and hospitalized child. She is also currently involved in several multicentered projects with the Vaccine Trial and Evaluation Unit (VTEU), Pediatric Health Information Systems (PHIS) research group through the Children’s Hospital Association (CHA). Finally, she has authored 21 peer-reviewed papers, more than 30 abstracts, 5 book chapters, and recently edited a book entitled, Curbside Consultations in Pediatric Infectious Diseases: 49 Clinical Questions.
Theoklis Zaoutis, MD, MSCE, FAAP
Dr Theoklis Zaoutis is the Thomas Frederick McNair Scott Professor of Pediatrics and Professor of Epidemiology at the Perelman School of Medicine at the University of Pennsylvania (PENN) and Associate Chief of the Division of Infectious Diseases at the Children’s Hospital of Philadelphia (CHOP). He is also Senior Scholar in the Center for Clinical Epidemiology and Biostatistics at PENN. He served as Director of the Antimicrobial Stewardship Program at CHOP from 2004 to 2010. He is the author of more than 150 peer-reviewed publications, most of which are in pediatric infectious diseases with a focus on healthcare-acquired infections, antimicrobial resistance, and antimicrobial use.
Dr. Zaoutis is currently the principal investigator for a National Institute for Allergy and Infectious Diseases (NIAID) contract that supports a randomized placebo-controlled trial of short-course antibiotic therapy for urinary tract infections in children as a strategy to reduce antimicrobial resistance. He also recently served as PI of an Agency for Healthcare Research and Quality (AHRQ)-funded cluster-randomized trial of an antimicrobial stewardship intervention.
Dr. Zaoutis currently serves on the CDC’s Office of Infectious Disease Board of Scientific Counselors’ Antimicrobial Resistance Working Group, NIAID’s Antimicrobial Resistance Leadership Group. The Antibiotic Resistance and Prescribing in European Children Working Group and the AAP’s Committee on Infectious Diseases (Red Book Committee). He is Editor-in Chief of the Journal of the Pediatric Infectious Diseases Society. He has served (1) on the Best Pharmaceuticals for Children Act Prioritization Meeting NICHD Expert Review Panel; (2) as an expert consultant for the CDC for Hospital-based Antimicrobial Surveillance; (3) as a co-investigator at the PENN Centers for Education on Research and Therapeutics administered by AHRQ; and (4) an associate editor for Pharmacoepidemiology and Drug Safety. In 2009, he was received the Society for Healthcare Epidemiology of America Pediatric Investigator Award.
Reviewers
Katherine Fleming-Dutra, MD, FAAP
Jesse Hackell, MD, FAAP
Adam L. Hersh, MD, PhD, FAAP
Lauri A. Hicks, DO, FAAP
AAP Staff
Linda O’Brien
Jennifer Frantz, MPH
Suzanne Kirkwood
Lori Morawski, MPH, CHES
Instructional Design
Teri Blommaert, Instructional Designer, Drake Resource Group, Inc
Since 1994, Drake Resource Group, Inc. has been an award-winning developer of customized and interactive learning solutions serving Fortune 1000 clients, small to mid-size business partners and their clients, as well as non-profit organizations. Our learning consulting business has served clients such as the American Academy of Pediatrics, Motorola, Allstate, Hewitt Associates, Caremark Rx, and OMNI Youth Services.
We focus on all aspects of an organization's learning needs—from initial planning phases to development, deployment, and evaluation. Learning solutions can be designed and delivered via in-person workshops, interactive webinars, eLearning courseware, printed formats, or a blended approach. For more information, visit www.DrakeRG.com.
EQIPP Planning Group
Gautham Suresh, MD, FAAP, Chair
Scott Carney, MD, FAAP
Danielle Casher, MD, MSHQ, FAAP
Christopher A. Cunha, MD, FAAP
Karen Kamachi, MD, FAAP
Suzanne Lazorick, MD, MPH, FAAP
Ramesh Sachdeva, MD, PhD, MPH, FAAP
William Southgate, MD, FAAP
Joyee Vachani, MD, FAAP
AAP Support
The mission of the Quality Improvement Innovation Network (QuIIN), a network of practicing pediatricians and their staff, is to improve care and outcomes for children and families. QuIIN does so by using quality improvement science to test practical tools, measures, and strategies for use in everyday pediatric practice, the child's medical home, as well as by informal assessment that provides practicing pediatrician perspective into evidenced-based recommendations and tools for implementation.
The measures and data collection tools presented in this course were tested by the Quality Improvement Innovation Network. Comments and feedback were incorporated.
Commercial Support
The EQIPP: Judicious Use of Antibiotics course is supported by an educational grant from GlaxoSmithKline, LLC.